Prognostic value of histopathology, stromal tumor infiltrating lymphocytes (sTILs) and adjuvant chemotherapy (AdjCT) in early stage triple negative breast cancer (TNBC).

被引：0
|
作者：
Leon-Ferre, Roberto Antonio
Polley, Mei-Yin
Liu, Heshan
Gilbert, Judith A.
Cafourek, Victoria
Hillman, David W.
Elkhanany, Ahmed
Akinhanmi, Margaret
Negron, Vivian
Boughey, Judy Caroline
Liu, Minetta C.
Ingle, James N.
Kalari, Krishna R.
Couch, Fergus
Visscher, Daniel W.
Goetz, Matthew P.
机构：
[1] Mayo Clin, Rochester, MN USA
[2] Alliance Stat, Rochester, MN USA
[3] Mayo Clin, Ctr Data, Rochester, MN USA
[4] Univ Missouri, Sch Med, Kansas City, MO 64108 USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2017年 / 35卷
关键词：
D O I：
10.1200/JCO.2017.35.15_suppl.533
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
533
引用
收藏
页数：5
相关论文
共 50 条
  • [1] Prognostic value of the neutrophil-to-lymphocyte ratio (NLR) and its relation to stromal tumor infiltrating lymphocytes (sTILs) in triple negative breast cancer (TNBC)
    Leon-Ferre, Roberto A.
    Polley, Mei-Yin
    Liu, Heshan
    Gilbert, Judith
    Cafourek, Victoria
    Hillman, David
    Negron, Vivian
    Boughey, Judy C.
    Liu, Minetta C.
    Ingle, James N.
    Kalari, Krishna
    Couch, Fergus J.
    Visscher, Daniel W.
    Goetz, Matthew P.
    CANCER RESEARCH, 2018, 78 (04)
  • [2] Prognostic value of tumor-infiltrating lymphocytes in patients with early-stage triple-negative breast cancers (TNBC) who did not receive adjuvant chemotherapy
    Park, J. H.
    Jonas, S. F.
    Bataillon, G.
    Criscitiello, C.
    Salgado, R.
    Loi, S.
    Viale, G.
    Lee, H. J.
    Dieci, M. V.
    Kim, S. -B.
    Vincent-Salomon, A.
    Curigliano, G.
    Andre, F.
    Michiels, S.
    ANNALS OF ONCOLOGY, 2019, 30 (12) : 1941 - 1949
  • [3] The role of stromal tumor infiltrating lymphocytes (sTILs) as a predictive biomarker for carboplatin-based neoadjuvant chemotherapy (NACT) in triple-negative breast cancer (TNBC).
    Walsh, Elaine M.
    O'Loughlin, Mark
    Shalaby, Aliaa
    Webber, Mark
    Kerin, Michael J.
    Glynn, Sharon A.
    Callagy, Grace
    Keane, Maccon M.
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [4] Prognostic value of tumour infiltrating lymphocytes (TILs) in patients with early-stage triple negative breast cancers (TNBC) in the absence of chemotherapy
    Park, J. H.
    Jonas, S. F.
    Dieci, M. V.
    Bataillon, G.
    Criscitiello, C.
    Viale, G.
    Salgado, R. F.
    Lee, H. J.
    Loi, S.
    Kim, S. -B.
    Curigliano, G.
    Vincent-Salomon, A.
    Andre, F.
    Michiels, S.
    ANNALS OF ONCOLOGY, 2019, 30 : 55 - 55
  • [5] Impact of histopathology, tumor-infiltrating lymphocytes, and adjuvant chemotherapy on prognosis of triple-negative breast cancer
    Leon-Ferre, Roberto A.
    Polley, Mei-Yin
    Liu, Heshan
    Gilbert, Judith A.
    Cafourek, Victoria
    Hillman, David W.
    Elkhanany, Ahmed
    Akinhanmi, Margaret
    Lilyquist, Jenna
    Thomas, Abigail
    Negron, Vivian
    Boughey, Judy C.
    Liu, Minetta C.
    Ingle, James N.
    Kalari, Krishna R.
    Couch, Fergus J.
    Visscher, Daniel W.
    Goetz, Matthew P.
    BREAST CANCER RESEARCH AND TREATMENT, 2018, 167 (01) : 89 - 99
  • [6] Impact of histopathology, tumor-infiltrating lymphocytes, and adjuvant chemotherapy on prognosis of triple-negative breast cancer
    Roberto A. Leon-Ferre
    Mei-Yin Polley
    Heshan Liu
    Judith A. Gilbert
    Victoria Cafourek
    David W. Hillman
    Ahmed Elkhanany
    Margaret Akinhanmi
    Jenna Lilyquist
    Abigail Thomas
    Vivian Negron
    Judy C. Boughey
    Minetta C. Liu
    James N. Ingle
    Krishna R. Kalari
    Fergus J. Couch
    Daniel W. Visscher
    Matthew P. Goetz
    Breast Cancer Research and Treatment, 2018, 167 : 89 - 99
  • [7] Prognostic Assessment of Stromal and Non-Stromal Tumor-Infiltrating Lymphocytes (TILs) in Triple-Negative Breast Cancer (TNBC)
    Ghosh, Toshi
    Goetz, Matthew
    Leon-Ferre, Roberto A.
    Liu, Heshan
    Polley, Mei-Yin C.
    Ingle, James
    Cafourek, Victoria L.
    Hillman, David W.
    Carter, Jodi
    Visscher, Daniel
    LABORATORY INVESTIGATION, 2018, 98 : 61 - 62
  • [8] Prognostic Assessment of Stromal and Non-Stromal Tumor-Infiltrating Lymphocytes (TILs) in Triple-Negative Breast Cancer (TNBC)
    Ghosh, Toshi
    Goetz, Matthew
    Leon-Ferre, Roberto A.
    Liu, Heshan
    Polley, Mei-Yin C.
    Ingle, James
    Cafourek, Victoria L.
    Hillman, David W.
    Carter, Jodi
    Visscher, Daniel
    MODERN PATHOLOGY, 2018, 31 : 61 - 62
  • [9] Prognostic value of tumor infiltrating lymphocytes (TILs) on residual disease after primary chemotherapy for triple-negative breast cancer (TNBC) patients
    Dieci, M. V.
    Criscitiello, C.
    Guarneri, V.
    Conte, P. F.
    Goubar, A.
    Charpy, C.
    Viale, G.
    Delaloge, S.
    Curigliano, G.
    Andre, F.
    EUROPEAN JOURNAL OF CANCER, 2013, 49 : S479 - S480
  • [10] Pitfalls in assessing stromal tumor infiltrating lymphocytes (sTILs) in breast cancer
    Kos, Zuzana
    Roblin, Elvire
    Kim, Rim S.
    Michiels, Stefan
    Gallas, Brandon D.
    Chen, Weijie
    van de Vijver, Koen K.
    Goel, Shom
    Adams, Sylvia
    Demaria, Sandra
    Viale, Giuseppe
    Nielsen, Torsten O.
    Badve, Sunil S.
    Symmans, W. Fraser
    Sotiriou, Christos
    Rimm, David L.
    Hewitt, Stephen
    Denkert, Carsten
    Loibl, Sibylle
    Luen, Stephen J.
    Bartlett, John M. S.
    Savas, Peter
    Pruneri, Giancarlo
    Dillon, Deborah A.
    Cheang, Maggie Chon U.
    Tutt, Andrew
    Hall, Jacqueline A.
    Kok, Marleen
    Horlings, Hugo M.
    Madabhushi, Anant
    van der Laak, Jeroen
    Ciompi, Francesco
    Laenkholm, Anne-Vibeke
    Bellolio, Enrique
    Gruosso, Tina
    Fox, Stephen B.
    Araya, Juan Carlos
    Floris, Giuseppe
    Hudecek, Jan
    Voorwerk, Leonie
    Beck, Andrew H.
    Kerner, Jen
    Larsimont, Denis
    Declercq, Sabine
    Van den Eynden, Gert
    Pusztai, Lajos
    Ehinger, Anna
    Yang, Wentao
    AbdulJabbar, Khalid
    Yuan, Yinyin
    NPJ BREAST CANCER, 2020, 6 (01)
12345